These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37512140)

  • 21. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.
    Kotsinas A; Sigala F; Garbis SD; Galyfos G; Filis K; Vougas K; Papalampros A; Johnson EE; Chronopoulos E; Georgakilas AG; Gorgoulis VG
    Curr Med Chem; 2015; 22(22):2666-79. PubMed ID: 26180004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-143/-145 in Cardiovascular Diseases.
    Zhao W; Zhao SP; Zhao YH
    Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype-genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs.
    Wu R; Lin Y; Liu X; Zhan C; He H; Shi M; Jiang Z; Shen B
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 31942979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
    Felekkis K; Papaneophytou C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma MicroRNA as a novel diagnostic.
    Szelenberger R; Kacprzak M; Saluk-Bijak J; Zielinska M; Bijak M
    Clin Chim Acta; 2019 Dec; 499():98-107. PubMed ID: 31499022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases.
    Joaquim VHA; Pereira NP; Fernandes T; Oliveira EM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.
    Pasławska M; Grodzka A; Peczyńska J; Sawicka B; Bossowski AT
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biology of circulating microRNAs in cardiovascular disease.
    Min PK; Chan SY
    Eur J Clin Invest; 2015 Aug; 45(8):860-74. PubMed ID: 26046787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on the roles of immune system-derived microRNAs in cardiovascular diseases.
    Roberts LB; Kapoor P; Howard JK; Shah AM; Lord GM
    Cardiovasc Res; 2021 Nov; 117(12):2434-2449. PubMed ID: 33483751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as biomarkers for clinical studies.
    Pogribny IP
    Exp Biol Med (Maywood); 2018 Feb; 243(3):283-290. PubMed ID: 28914096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MiRNAs in the diagnosis of cardiovascular diseases associated with type 2 diabetes mellitus and obesity].
    Shvangiradze TA; Bondarenko IZ; Troshina EA; Shestakova MV
    Ter Arkh; 2016; 88(10):87-92. PubMed ID: 28635856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA as Biomarkers and Diagnostics.
    Wang J; Chen J; Sen S
    J Cell Physiol; 2016 Jan; 231(1):25-30. PubMed ID: 26031493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications.
    Fernández-Moreno R; Torre-Cisneros J; Cantisán S
    RNA Biol; 2021 Dec; 18(12):2194-2202. PubMed ID: 34039247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs: Biomarkers for cardiovascular disease in patients with diabetes mellitus.
    Briasoulis A; Tousoulis D; Vogiatzi G; Siasos G; Papageorgiou N; Oikonomou E; Genimata V; Konsola T; Stefanadis C
    Curr Top Med Chem; 2013; 13(13):1533-9. PubMed ID: 23745805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.